Weight-loss drug Belviq not linked to heart problems, finds study
The Guardian -------- For the first time, a drug has been shown to help people lose weight and keep it off for several years without raising their risk of heart problems. There is hope that lorcaserin, sold in US since 2013 under the name Belviq, could help tackle the obesity epidemic. The drug, an appetite suppressant that works by stimulating brain chemicals to give a feeling of fullness, is the first of several new weight-loss medicines to succeed in a long-term heart safety study now required by US federal regulators to stay on the market. To learn more click on the picture below to read the article.